Laman UtamaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Tutup sebelumnya
$12.67
Julat hari
$12.82 - $12.95
Julat tahun
$10.13 - $16.31
Permodalan pasaran
63.07B HKD
Bilangan Purata
12.09K
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 147.36B | -5.19% |
Perbelanjaan pengendalian | 6.78B | 4.18% |
Pendapatan bersih | 1.85B | -26.34% |
Margin untung bersih | 1.26 | -22.22% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 4.76B | -25.05% |
Kadar cukai berkesan | 22.34% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 43.33B | 26.05% |
Jumlah aset | 429.58B | 2.85% |
Jumlah liabiliti | 307.15B | 0.84% |
Jumlah ekuiti | 122.43B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.52 | — |
Pulangan pada aset | 2.44% | — |
Pulangan pada modal | 4.69% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.85B | -26.34% |
Tunai daripada operasi | -20.50B | -678.47% |
Tunai daripada pelaburan | -519.26J | -167.92% |
Tunai daripada pembiayaan | 10.78B | 5,713.58% |
Perubahan bersih dalam tunai | -10.24B | -512.13% |
Aliran tunai bebas | 2.71B | 108.45% |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
113,635
